De Novo Foodlabs Lands Fresh Funding to Commercialize Longevity Protein NanoFerrin™
19 Agosto 2024 - 8:07AM
Business Wire
Investment to accelerate De Novo’s
innovation in animal-free functional nutrition in the
U.S.
De Novo Foodlabs (De Novo), a food technology company focused on
creating rare protein-based functional ingredients, has announced
fresh capital, bringing its total investment to $4 million. This
investment will enable De Novo to fast-track the commercialization
of its revolutionary precision fermented lactoferrin product,
NanoFerrin™. The raise, spearheaded by sustainable protein venture
capital firm Joyful Ventures, highlights the immense potential of
De Novo's state-of-the-art, animal-free protein solutions to
reshape the health and wellness landscape.
Lactoferrin, a functional protein primarily found in milk, plays
a crucial role in infant development, and offers numerous health
benefits for adults, such as improved immunity, brain health, iron
absorption, gut health, and longevity. Lactoferrin has been shown
to be effective in alleviating aging-related changes through its
anti-oxidation, anti-cellular senescence, and anti-inflammation
properties, among others. Traditional extraction methods from cow
milk are not only prohibitively expensive but also plagued by
sustainability and ethical challenges. De Novo Foodlabs was
established to tackle these issues head-on by developing an
alternative lactoferrin that delivers all the health benefits
without the ethical and environmental drawbacks.
“The lactoferrin market has long been hindered by high prices
and inconsistent supply,” said Jean Louwrens, CEO and Co-Founder of
De Novo Foodlabs. “Our team of leading scientists and engineers has
dedicated themselves to overcoming these challenges through
precision fermentation technology, and we are thrilled to have
achieved a breakthrough. NanoFerrin is not only more affordable and
eco-friendly; importantly, it also provides a reliable supply
source compared to traditional bovine lactoferrin products. We are
excited to collaborate with our investors to elevate De Novo to new
heights.”
"De Novo Foodlabs exemplifies the innovation and sustainability
we champion at Joyful Ventures," stated Milo Runkle, General
Partner at Joyful Ventures, and Co-Founder of the Good Food
Institute. "Their advancements in precision fermentation technology
and dedication to creating impactful alternatives to high-value
animal-derived ingredients pave the way for scalable and profitable
industry solutions.” As part of the investment, Mr. Runkle will
join De Novo’s Board of Directors.
This latest funding round follows initial investments from
Sustainable Food Ventures, Siddhi Capital, Pascual Innoventures,
UM6P Ventures, Cult Food Science and Prithvi Capital, bringing De
Novo’s total funding to $4 million since its inception in 2021.
The global lactoferrin market, valued at $773 million in 2023,
is projected to grow annually by 15.8% over the next decade,
presenting tremendous opportunities for innovators and investors to
enhance the supply chain and satisfy consumer demand. De Novo’s
NanoFerrin offers an unmatched ingredient for the food, beverage,
and supplements sectors, facilitating rapid market expansion and
category growth.
About De Novo Foodlabs:
Founded in 2021, De Novo Foodlabs is at the cutting edge of
nutrition science and technology. The company’s mission is to be a
catalyst in the development of next-generation nutrition by merging
world-class science, deep protein expertise, and proven biopharma
technology. Committed to replacing animal proteins in the food
supply chain, De Novo focuses on protein-based functional
ingredients. Their flagship product, NanoFerrin™, offers a
sustainable, cost-effective, and scalable alternative to
traditional lactoferrin, meeting the growing demand in the food
& beverage and supplements industries. Learn more at
http://www.denovofoodlabs.com/
Print-ready photos of the De Novo team and NanoFerrin can be
downloaded here. (Credit De Novo Foodlabs).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240819183469/en/
Andrew Moore (225) 348-2075
andrew@narrativepublicaffairs.com